ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 157 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $816,000 | -30.4% | 13,203 | -32.4% | 0.02% | -17.9% |
Q3 2019 | $1,173,000 | -2.7% | 19,532 | +36.8% | 0.03% | +7.7% |
Q2 2019 | $1,205,000 | +261.9% | 14,275 | +279.5% | 0.03% | +271.4% |
Q3 2018 | $333,000 | -92.6% | 3,762 | -90.4% | 0.01% | -91.9% |
Q2 2018 | $4,506,000 | +72.1% | 39,026 | +20.6% | 0.09% | +56.4% |
Q1 2018 | $2,619,000 | +71.1% | 32,371 | +25.1% | 0.06% | +66.7% |
Q4 2017 | $1,531,000 | -68.0% | 25,882 | -81.9% | 0.03% | -80.6% |
Q4 2016 | $4,779,000 | +30.4% | 142,669 | +3.6% | 0.17% | +50.4% |
Q3 2016 | $3,666,000 | +125.3% | 137,752 | +86.7% | 0.11% | +109.3% |
Q2 2016 | $1,627,000 | -54.8% | 73,772 | -39.8% | 0.05% | -47.6% |
Q1 2016 | $3,597,000 | +78.4% | 122,457 | +103.1% | 0.10% | +114.6% |
Q4 2015 | $2,016,000 | – | 60,292 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |